Table-Top Water Pitcher to Reduce Arsenic Exposure Among Well Users in New Hampshire
Launched by TRUSTEES OF DARTMOUTH COLLEGE · Aug 1, 2025
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether a special table-top water pitcher with a filter can help reduce arsenic, a harmful substance, in the drinking water of people who use private wells in New Hampshire. The study wants to see if using this pitcher lowers arsenic levels in both the water and the body over time, and to understand what makes it easier or harder for people to keep using the filter regularly. Researchers are also interested in whether factors like household income or owning a home affect how consistently people use the pitcher.
To join the study, participants must be 18 or older, live in New Hampshire, get their main healthcare at certain clinics, use a private well for most of their drinking water, and do most of their cooking at home. They also need to have arsenic levels in their water above a certain limit. Participants will receive a free water filter pitcher and replacement filters, use the pitcher as instructed, and provide water and urine samples at the start, after 4 weeks, and after 12 weeks. They will also fill out online questionnaires during these times. This study is not yet recruiting but aims to help families using well water reduce their exposure to arsenic safely and effectively.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years or older
- • NH resident
- • Receiving primary care at Dartmouth Hitchcock Clinics - Concord
- • Use a private water system as primary drinking water source
- • Do majority (\>50%) of food preparation in home
- • Interested in receiving a free water arsenic test kit
- • Water arsenic \>5 micrograms/L upon testing
- Exclusion Criteria:
- • Use or plan to use a mitigation strategy to reduce exposure to arsenic-contaminated drinking water
About Trustees Of Dartmouth College
The Trustees of Dartmouth College serve as the governing body overseeing the institution's strategic direction, including its commitment to advancing research and innovation in the field of healthcare. With a strong emphasis on academic excellence and interdisciplinary collaboration, the Trustees facilitate the development and management of clinical trials that aim to enhance medical knowledge and improve patient outcomes. Their dedication to ethical research practices and adherence to regulatory standards underscores their role in fostering a culture of scientific inquiry and discovery at Dartmouth, ultimately contributing to the advancement of public health and medical education.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported